Skip to main content
. Author manuscript; available in PMC: 2013 May 2.
Published in final edited form as: Anticancer Res. 2010 Jun;30(6):2153–2160.

Figure 6.

Figure 6

Tumor burden in mice after mesothelioma cell injection followed by daily injection of PBS or AMD3100. (A) Total tumor number significantly increased in PBS-injected but not in AMD3100-injected mice. (B) Initial higher percentage of tumor spheroids in AMD3100-injected mice compared to control. (C) Greater increasing trend in total tumor area in control than in AMD3100-injected mice. (*p-value ≤ 0.05, student’s t-test)